William Aird/X
Sep 2, 2025, 08:49
Why Polycythemia Vera Doesn’t Raise EPO Levels Explained by William Aird
William Aird, Professor of Medicine at Harvard Medical School, shared a post on X:
“Why PV Does Not Increase EPO
In PV, renal O2-sensing cells sit in a high-flow, low-extraction zone. Extra O₂ content outweighs modest viscosity effects, so HIF stays off & EPO stays low. The ‘falling off the curve’ in DO₂ vs Hct doesn’t hit them, unless Hct gets extremely high.”
Learn the latest with Hemostasis Today.
-
Jul 24, 2026, 21:09Ifeanyichukwu Ifechidere: The Monitoring Dilemma in DOAC Therapy – Concentration vs. Real-Time Effect
-
Jul 24, 2026, 20:14Idris Syed: Presenting Our Omics and VTE Research at ISTH 2026
-
Jul 24, 2026, 19:58Wolfgang Miesbach: Why Patient-Reported Outcomes (PROs) Are Essential for Hemophilia Gene Therapy
-
Jul 24, 2026, 19:43Emilie Langenhan: An Unforgettable Experience at ISTH 2026
-
Jul 24, 2026, 17:16Mona Ranade։ Can Artificial Intelligence Accelerate Stroke Treatment?
-
Jul 24, 2026, 17:06Eunice Obinna: Hemoglobin and Hematocrit – What Do They Really Tell Us?
-
Jul 24, 2026, 16:52Subodh Grewal: RBC and Platelet Histogram Interpretation
-
Jul 24, 2026, 16:47Samwel Mikaye: Advancing the Global Fight Against Postpartum Hemorrhage
-
Jul 24, 2026, 16:17Michele Spino Bolles: How Stroke Certification Standards Improve Patient Outcomes